Morgan Stanley’s Virtus LifeSci Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $163K | Buy |
8,455
+11
| +0.1% | +$213 | ﹤0.01% | 5929 |
|
2025
Q1 | $148K | Sell |
8,444
-3,053
| -27% | -$53.6K | ﹤0.01% | 5851 |
|
2024
Q4 | $275K | Sell |
11,497
-1,656
| -13% | -$39.7K | ﹤0.01% | 5668 |
|
2024
Q3 | $368K | Sell |
13,153
-8,146
| -38% | -$228K | ﹤0.01% | 5535 |
|
2024
Q2 | $538K | Sell |
21,299
-18,991
| -47% | -$480K | ﹤0.01% | 5261 |
|
2024
Q1 | $1.17M | Buy |
40,290
+22,068
| +121% | +$643K | ﹤0.01% | 4875 |
|
2023
Q4 | $446K | Buy |
18,222
+11,706
| +180% | +$286K | ﹤0.01% | 5667 |
|
2023
Q3 | $128K | Buy |
6,516
+1,744
| +37% | +$34.2K | ﹤0.01% | 5767 |
|
2023
Q2 | $114K | Sell |
4,772
-840
| -15% | -$20.1K | ﹤0.01% | 5888 |
|
2023
Q1 | $123K | Sell |
5,612
-800
| -12% | -$17.5K | ﹤0.01% | 5931 |
|
2022
Q4 | $160K | Sell |
6,412
-465
| -7% | -$11.6K | ﹤0.01% | 5760 |
|
2022
Q3 | $169K | Sell |
6,877
-96
| -1% | -$2.36K | ﹤0.01% | 5807 |
|
2022
Q2 | $151K | Buy |
6,973
+251
| +4% | +$5.44K | ﹤0.01% | 6028 |
|
2022
Q1 | $188K | Sell |
6,722
-799
| -11% | -$22.3K | ﹤0.01% | 5958 |
|
2021
Q4 | $290K | Buy |
7,521
+703
| +10% | +$27.1K | ﹤0.01% | 5866 |
|
2021
Q3 | $312K | Sell |
6,818
-6,953
| -50% | -$318K | ﹤0.01% | 5758 |
|
2021
Q2 | $688K | Buy |
13,771
+1,047
| +8% | +$52.3K | ﹤0.01% | 5316 |
|
2021
Q1 | $654K | Buy |
12,724
+2,023
| +19% | +$104K | ﹤0.01% | 4998 |
|
2020
Q4 | $531K | Sell |
10,701
-3,571
| -25% | -$177K | ﹤0.01% | 5046 |
|
2020
Q3 | $556K | Sell |
14,272
-17,279
| -55% | -$673K | ﹤0.01% | 4583 |
|
2020
Q2 | $1.36M | Buy |
31,551
+12,587
| +66% | +$544K | ﹤0.01% | 3929 |
|
2020
Q1 | $556K | Buy |
18,964
+5,602
| +42% | +$164K | ﹤0.01% | 4316 |
|
2019
Q4 | $508K | Buy |
13,362
+4,361
| +48% | +$166K | ﹤0.01% | 4916 |
|
2019
Q3 | $214K | Buy |
9,001
+1,480
| +20% | +$35.2K | ﹤0.01% | 5091 |
|
2019
Q2 | $217K | Buy |
7,521
+2,372
| +46% | +$68.4K | ﹤0.01% | 4989 |
|
2019
Q1 | $147K | Buy |
5,149
+103
| +2% | +$2.94K | ﹤0.01% | 5215 |
|
2018
Q4 | $117K | Sell |
5,046
-5,283
| -51% | -$122K | ﹤0.01% | 5492 |
|
2018
Q3 | $357K | Sell |
10,329
-6,586
| -39% | -$228K | ﹤0.01% | 5177 |
|
2018
Q2 | $553K | Buy |
16,915
+14,207
| +525% | +$464K | ﹤0.01% | 5033 |
|
2018
Q1 | $89K | Buy |
2,708
+1,308
| +93% | +$43K | ﹤0.01% | 5736 |
|
2017
Q4 | $40K | Hold |
1,400
| – | – | ﹤0.01% | 5881 |
|
2017
Q3 | $41K | Hold |
1,400
| – | – | ﹤0.01% | 5838 |
|
2017
Q2 | $34K | Sell |
1,400
-35
| -2% | -$850 | ﹤0.01% | 5954 |
|
2017
Q1 | $34K | Sell |
1,435
-65
| -4% | -$1.54K | ﹤0.01% | 5938 |
|
2016
Q4 | $28K | Sell |
1,500
-2,470
| -62% | -$46.1K | ﹤0.01% | 5907 |
|
2016
Q3 | $90K | Buy |
3,970
+2,600
| +190% | +$58.9K | ﹤0.01% | 5351 |
|
2016
Q2 | $25K | Hold |
1,370
| – | – | ﹤0.01% | 5772 |
|
2016
Q1 | $26K | Sell |
1,370
-400
| -23% | -$7.59K | ﹤0.01% | 5838 |
|
2015
Q4 | $51K | Buy |
1,770
+400
| +29% | +$11.5K | ﹤0.01% | 5707 |
|
2015
Q3 | $36K | Buy |
1,370
+1,300
| +1,857% | +$34.2K | ﹤0.01% | 5845 |
|
2015
Q2 | $3K | Sell |
70
-100
| -59% | -$4.29K | ﹤0.01% | 6466 |
|
2015
Q1 | $5K | Buy |
+170
| New | +$5K | ﹤0.01% | 6333 |
|